Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuronetics (STIM) Net Income (2017 - 2025)

Historic Net Income for Neuronetics (STIM) over the last 9 years, with Q3 2025 value amounting to -$9.5 million.

  • Neuronetics' Net Income fell 78.28% to -$9.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$45.7 million, marking a year-over-year decrease of 3102.25%. This contributed to the annual value of -$41.8 million for FY2024, which is 1631.83% down from last year.
  • Neuronetics' Net Income amounted to -$9.5 million in Q3 2025, which was down 78.28% from -$10.0 million recorded in Q2 2025.
  • In the past 5 years, Neuronetics' Net Income registered a high of -$6.3 million during Q4 2023, and its lowest value of -$13.2 million during Q4 2024.
  • For the 5-year period, Neuronetics' Net Income averaged around -$9.5 million, with its median value being -$9.5 million (2024).
  • Data for Neuronetics' Net Income shows a peak YoY increase of 3360.25% (in 2021) and a maximum YoY decrease of 13861.65% (in 2021) over the last 5 years.
  • Over the past 5 years, Neuronetics' Net Income (Quarter) stood at -$8.0 million in 2021, then fell by 12.12% to -$8.9 million in 2022, then increased by 29.85% to -$6.3 million in 2023, then crashed by 110.96% to -$13.2 million in 2024, then rose by 27.98% to -$9.5 million in 2025.
  • Its Net Income stands at -$9.5 million for Q3 2025, versus -$10.0 million for Q2 2025 and -$12.9 million for Q1 2025.